ダウンロード数: 161
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
16_0619.pdf | 328.17 kB | Adobe PDF | 見る/開く |
タイトル: | Double Blind法によるRifampicinの検討 |
その他のタイトル: | A double blind study of rifampicin |
著者: | 西浦, 常雄 田村, 公一 上野, 一恵 二宮, 敬宇 神谷, 春子 |
著者名の別形: | Nishiura, Tsuneo Tamura, Masakazu Ueno, Kazue Ninomiya, Keiu Kamiya, Haruko |
キーワード: | Cephalosporins/therapeutic use Clinical Trials as Topic Drug Resistance, Microbial Humans Piperidines/therapeutic use Rifampin/administration & dosage/adverse effects/therapeutic use Urinary Tract Infections/drug therapy |
発行日: | Oct-1970 |
出版者: | 京都大学医学部泌尿器科学教室 |
誌名: | 泌尿器科紀要 |
巻: | 16 |
号: | 10 |
開始ページ: | 619 |
終了ページ: | 623 |
抄録: | A double blind study was made on rifampicin (RFP) and cephaloglycin (CEG) for 55 nonspecific urinary tract infections. RFP was administered 900 mg/day (b. i. d.) and CEG 2 g/day (q. i. d.), each for three days. Of 42 acute cystitis, 23 were treated with RPF and a11 responded, whereas 19 were treated with CEG and 17 responded (Table 2). There was, however, no statistically significant difference between the effectiveness rate of both drugs (p=O.1988). Out of 13 cases of urinary tract infection other than acute cystitis, 6 were treated with RFP and 3 were cured while 7 with CEG and 4 cured (Table 3). MIC of RFP for the isolated organisms from the cases above mostly ranged between 6.25 and 25 mcg/ml (Table 5). Disappearance rate of urinary microorganism after drug administration for acute cystitis was 96 % CZZ/Z3) in RFP-group and 63 % (12/19) in CEG-group. This shows superiority of RFP (p=O.0098). Even after three days' administration, increased RFP-resistance was proved in 4 strains (Table 7). No side-effects were encountered. |
URI: | http://hdl.handle.net/2433/121174 |
PubMed ID: | 4920593 |
出現コレクション: | Vol.16 No.10 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。